FATIGUE SEVERITY SCALE (FSS) IN INDIVIDUALS WITH RHEUMATOID ARTHRITIS: TAMIL VERSIO
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
- Registration Number
- CTRI/2023/06/053567
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients who are clinically diagnosed with rheumatoid arthritis
age: 20 to 65 years
Exclusion Criteria
cognitively unstable, participants with co-existing disorder of other system influencing fatigue, non-tamil speaking, unable to read tamil, patients associated with neurologicsl problems
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FATIGUE SEVERITY SCALETimepoint: ONE TIME ASSESSMENT, NOT APPLICABLE FOR 4 WEEKS AND 8 WEEKS
- Secondary Outcome Measures
Name Time Method SF-12 <br/ ><br>HAQ-DITimepoint: ONE TIME ASSESSMENT, NOT APPLICABLE FOR 4 WEEKS AND 8 WEEKS
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie fatigue in rheumatoid arthritis patients with rheumatoid factor?
How does the Tamil version of FSS compare to other validated fatigue scales in rheumatoid arthritis populations?
Are there specific biomarkers associated with fatigue severity in M059 rheumatoid arthritis patients?
What adverse events are commonly reported in rheumatoid arthritis trials using observational fatigue assessment tools?
What combination therapies show promise in managing fatigue for rheumatoid arthritis patients with rheumatoid factor?